Cited by

• Short tail with skin lesion phenotype occurs in transgenic mice with keratin-14 promoter-directed expression of mutant CXCR2.

  Yu Y, Su Y, Opalenik SR, Sobolik-Delmaire T, Neel NF, Zaja-Milatovic S, Short ST, Sai J, Richmond A. Yu Y, et al. J Leukoc Biol. 2008 Aug;84(2):406-19. doi: 10.1189/jlb.0807544. Epub 2008 May 27. J Leukoc Biol. 2008. PMID: 18505935 Free PMC article.
• The TGFα-EGFR-Akt signaling axis plays a role in enhancing proinflammatory chemokines in triple-negative breast cancer cells.

  Ignacio RMC, Gibbs CR, Lee ES, Son DS. Ignacio RMC, et al. Oncotarget. 2018 Jun 29;9(50):29286-29303. doi: 10.18632/oncotarget.25389. eCollection 2018 Jun 29. Oncotarget. 2018. PMID: 30034618 Free PMC article.
• CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer.

  Ignacio RMC, Dong YL, Kabir SM, Choi H, Lee ES, Wilson AJ, Beeghly-Fadiel A, Whalen MM, Son DS. Ignacio RMC, et al. Oncotarget. 2018 Jan 15;9(11):9751-9765. doi: 10.18632/oncotarget.24231. eCollection 2018 Feb 9. Oncotarget. 2018. PMID: 29515768 Free PMC article.
• Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.

  Ha H, Debnath B, Neamati N. Ha H, et al. Theranostics. 2017 Apr 7;7(6):1543-1588. doi: 10.7150/thno.15625. eCollection 2017. Theranostics. 2017. PMID: 28529637 Free PMC article. Review.
• ELR+ CXC chemokine expression in benign and malignant colorectal conditions.

  Rubie C, Frick VO, Wagner M, Schuld J, Gräber S, Brittner B, Bohle RM, Schilling MK. Rubie C, et al. BMC Cancer. 2008 Jun 25;8:178. doi: 10.1186/1471-2407-8-178. BMC Cancer. 2008. PMID: 18578857 Free PMC article.